Read + Share
Pu X, Zhou Y, Kong Y, Chen B, et al. Efficacy and safety of dacomitinib in treatment-naive patients with advanced
NSCLC harboring uncommon EGFR mutation: an ambispective cohort study. BMC Cancer 2023;23:982.
PMID: 37840124
|
 |
|
Pu X, Zhou Y, Kong Y, Chen B, et al. Efficacy and safety of dacomitinib in treatment-naive patients with advanced
NSCLC harboring uncommon EGFR mutation: an ambispective cohort study. BMC Cancer 2023;23:982.
PMID: 37840124
|
|
|
|